The CBO findings estimate the direct spending and revenue effects of the recently passed House Resolution 6079, the Repeal Obamacare Act. While the repeal would reduce direct spending by $890 billion, it would reduce revenue by $1 trillion.
Revenue lost in the House repeal of the PPACA includes penalty payments from employers and uninsured individuals, revenues from the excise tax on high-premium insurance plans and net savings from other coverage-related effects, according to the CBO. Those taxes drive much of the funding of the 2010 healthcare law.
The CBO acknowledges its projections are “quite uncertain because they are based, in large part, on projections of the effects of the [PPACA], which are themselves highly uncertain.”
The House’s Repeal of Obamacare Act is unlikely to pass through the Democrat-controlled Senate, as Majority Leader Harry Reid (D-Nev.) has vowed to block any vote to repeal the PPACA.
More Articles on the CBO:
CBO: Supreme Court Decision to Make Medicaid Expansion Optional Saves $84B
CBO: Federal Healthcare Expenses Set to Double Over Next Decade
CBO: Healthcare Spending to Dominate Federal Budget
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
